Status:
TERMINATED
Double Tract Anastomosis and Gastric Tube Anastomosis to Proximal Gastrectomy
Lead Sponsor:
Jian-Kun Hu
Conditions:
Complications
Quality of Life
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Gastric cancer as one of the most common gastrointestinal cancers, radical resection of primary lesions combined with dissection of regional lymph-nodes is acknowledged by surgeons all over the world....
Detailed Description
Standard Operating Procedure (SOP) 1. Preoperative evaluation Patients satisfied with inclusion/exclusion criteria will be informed to join in the clinical study and signature the inform consent. 2. ...
Eligibility Criteria
Inclusion
- Preoperative endoscopy and biopsy confirmed upper third gastric adenocarcinoma, and predictively feasible of proximal gastrectomy ;
- Predictively resectable diseases, early gastric cancer, of preoperative staging JGCA 14th Edition cT1N0M0-T2N0M0;
- Age：≤75 years, or ≥18 years;
- Without serious disease and malignance disease;
- Patients without previous history of upper abdominal surgery;
- WHO performance score ≤2, ASA score ≤3;
- No limit to sexual and race;
- informed consent required.
Exclusion
- With the history of the malignance disease;
- Patients with other severe complications cannot tolerate surgery: such as severe heart and lung diseases, heart function below clinical stage 2, uncontrollable hypertension, pulmonary infection, moderate to severe COPD, chronic bronchitis, severe diabetes and / or renal insufficiency, severe hepatitis and / or function below the rank of CHILD B grade, and severe malnutrition, etc.
- Patients treated with neoadjuvant chemotherapy or radiation therapy which might affect the efficacy observation;
- Severity mental diseases;
- After signature the Clinical trial agreement, patients and their agent will quit the trial;
- primary lesion cannot be resected in the pattern of transabdominal proximal gastrectomy, but for total gastrectomy, Whipple's procedure, or combined organ resection or with a transthoracic approach surgery
- After signature the Clinical trial agreement, patients and their agent will quit the trial.
Key Trial Info
Start Date :
December 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
4 Patients enrolled
Trial Details
Trial ID
NCT02288728
Start Date
December 1 2014
End Date
December 1 2017
Last Update
December 11 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
West China Hospital, Sichuan University
Chengdu, Sichuan, China, 610041